EBF3 suppresses lung adenocarcinoma progression and immune evasion via transcriptional repression of CCL24.

Saved in:
Bibliographic Details
Title: EBF3 suppresses lung adenocarcinoma progression and immune evasion via transcriptional repression of CCL24.
Authors: Li L; Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, shanghai, 200030, China. lilan1316@163.com.; Shanghai Key Laboratory of Thoracic Tumor Biotherapy, shanghai, 200030, China. lilan1316@163.com., Yang Y; Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, shanghai, 200030, China.; Shanghai Key Laboratory of Thoracic Tumor Biotherapy, shanghai, 200030, China., Li D; Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, shanghai, 200030, China.; Shanghai Key Laboratory of Thoracic Tumor Biotherapy, shanghai, 200030, China., Chen C; Shanghai Jiao Tong University School of Medicine, shanghai, 200025, China., Mu X; Shanghai Jiao Tong University School of Medicine, shanghai, 200025, China., Wu J; Shanghai Jiao Tong University School of Medicine, shanghai, 200025, China., Yuan J; Shanghai Jiao Tong University School of Medicine, shanghai, 200025, China. yuanjin1316@shsmu.edu.cn.
Source: Cellular oncology (Dordrecht, Netherlands) [Cell Oncol (Dordr)] 2026 Apr 22; Vol. 49 (3). Date of Electronic Publication: 2026 Apr 22.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Electronic Cited Medium: Internet ISSN: 2211-3436 (Electronic) Linking ISSN: 22113428 NLM ISO Abbreviation: Cell Oncol (Dordr) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2211-3436
DOI:10.1007/s13402-026-01212-7